Disease-specific autoantibodies in patients with acute liver failure: The King's College London experience

Hepatology

Volumn 47, Issue 3, 2008, Pages 1096-1097

  Bernal, William ^a   Meda, Francesca ^a   Ma, Yun ^a   Bogdanos, Dimitrios P ^a   Vergani, Diego ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; BIOCHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; LETTER; LIVER CIRRHOSIS; LIVER FAILURE; OXIDATIVE STRESS; PRIORITY JOURNAL; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LIVER MITOCHONDRION; NOTE; REPRODUCIBILITY; UNITED KINGDOM;

AUTOANTIBODIES; AUTOIMMUNITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LIVER FAILURE, ACUTE; LONDON; MITOCHONDRIA, LIVER; REPRODUCIBILITY OF RESULTS;

EID: 40949108859     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22179     Document Type: Letter

References (8)

1. Leung PS, Rossaro L, Davis PA, Park O, Tanaka A, Kikuchi K, et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. HEPATOLOGY 2007;46:1436-1442.
2. Ferret PJ, Hammoud R, Tulliez M, Tran A, Trebeden H, Jaffray P, et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. HEPATOLOGY 2001;33:1173-1180.
3. Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, et al. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. HEPATOLOGY 2003;38:1018-1025.
4. Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007;47:664-670.
5. Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. HEPATOLOGY 2002;35:658-664.
6. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004;41:31-37.
7. Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005;25:63-71.
8. Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006;176:4484-4491.